NAUTILUS BIOTECHNOLOGY INC (NAUT)

Earnings Surprise: Navitas Semiconductor reported second-quarter revenue that exceeded Wall Street forecasts. Management provided upbeat guidance for the third quarter, projecting double-digit sequential growth and a return to year-over-year expansion. Executives highlighted accelerating demand ...

555,921 shares of the stock traded hands, compared to its average volume of 480,796. Nautilus Biotechnology has a 12 month low of $0.62 and a 12 month high of $4.31. The company has a market cap of $130.26 million, a price-to-earnings ratio of -2.28 and a beta of 0.80.

Nautilus Biotechnology has a fifty-two week low of $0.62 and a fifty-two week high of $4.31. The stock has a 50-day simple moving average of $2.08 and a 200 day simple moving average of $2.43. Nautilus Biotechnology (NASDAQ:NAUT – Get Free Report) last posted its earnings results on Tuesday, ...

Development-stage proteomics firm Nautilus Biotechnology posted a $29.2M first-half 2026 net loss, with R&D of $19.3M, while ending June 30, 2026 with $84.0M in cash and short-term investments and $129.2M including long-term investments, and planning commercial launch of its Voyager platform ...

Jul 28, 2026, 1:23 PM ETNautilus Biotechnology, Inc. (NAUT) Stock ... Nautilus Biotechnology, Inc. (NAUT) Q2 2026 Earnings Call July 28, 2026 8:30 AM EDT